Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.
Date: March 17, 2008
Proper name(s): Melissa officinalis L. (Lamiaceae) (USDA 2001)
Common name(s): Lemon balm, melissa (USDA 2001)
Source material(s): Aerial parts (EMEA 2007)
Route(s) of administration: Oral (EMEA 2007)
Dosage form(s): Those suited to the allowable route(s) of administration.
This monograph is not intended to include food-like dosage forms such as bars, chewing gums or beverages.
Use(s) or Purpose(s): Statement(s) to the effect of:
Dose(s):
Subpopulation: Adults and adolescents, ≥ 13 years (EMEA 2007)
Quantity: Preparations equivalent to 0.4-13.5 g dried aerial parts, per day (EMEA 2007)
See Appendix 1 for examples of appropriate dosage preparations, frequencies of use and directions for use, according to cited references. The purpose of Appendix 1 is to provide guidance to industry.
Duration of use: No statement required.
Risk information: Statement(s) to the effect of:
Caution(s) and warning(s):
Sleep aid: Consult a health care practitioner if sleeplessness persists continuously for more than 3 weeks (chronic insomnia) (Berardi et al. 2002; Dipiro et al. 2002).
All uses:
Contraindication(s): No statement required.
Known adverse reaction(s): Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness (EMEA 2007).
Non-medicinal ingredients: Must be chosen from the current NHPD List of Acceptable Non-medicinal Ingredients and must meet the limitations outlined in the list.
Specifications:
References:
Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy: A Pathophysiological Approach, 5th edition. New York (NY): McGraw-Hill Co. Inc.; 2002
EMEA 2007. European Medicines Agency. Community Monograph on . London (UK): EMEA Committee on Herbal Medicinal Products (HMPC), 31 October 2007. [Accessed 2008-03-17]. Available at: http://www.emea.europa.eu/pdfs/human
/hmpc/melissae_folium/534107enfin.pdf
USDA 2001: United States Department of Agriculture, Agricultural Research Service, National Genetic Resources Program. Germplasm Resources Information Network (GRIN). Melissa officinalis L. National Germplasm Resources Laboratory, Beltsville (MD). [Accessed 2008-03-17]. Available from: http://www.ars-grin.gov/cgi-bin/npgs/html/tax_search.pl
Appendix 1: Examples of appropriate dosage preparations, frequencies of use and directions for use (EMEA 2007)
Dried aerial parts: 1.5-4.5 g, 1-3 times per day
Infusion: 1.5-4.5 g dried aerial parts, 1-3 times per day
Directions for use: Pour 150 ml of boiling water over dried aerial parts and infuse for 5-15 minutes.
Fluidextract: 2-4 g dried equivalent, 1-3 times per day
(1:1, 45% ethanol, 2-4 ml)
Tincture: 0.4-1.2 g dried equivalent, 1-3 times per day
(1:5, 45% ethanol, 2-6 ml)